Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 11 to 20 of 333 resources

  • Legal Barriers for Providing HCV Community Testing in Europe
    This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.
    UK, Rest of World Reports & Research PDF
  • HCV Action & BVHG National Hepatitis C ODN Stakeholder Event: Presentations
    On Thursday 4th July, HCV Action held a National Hepatitis C ODN Stakeholder Event, in partnership with the British Viral Hepatitis Group. The event - HCV Action's biggest to date - brought ODN representatives together to discuss the opportunities and challenges associated with the recently-announced NHS England elimination deal.
    England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF
  • EMCDDA on models of care for hepatitis C in drugs services
    The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.
    UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF
  • Surveillance of hepatitis C testing, diagnosis and treatment in Scotland, 2019 update
    This Health Protection Scotland report outlines that there were 1,423 new diagnoses of hepatitis C antibody-positivity in Scotland in 2018, the lowest number of new hepatitis C antibody diagnoses in Scotland since 1996. It is estimated that approximately 21,000 individuals were living with chronic hepatitis C infection in Scotland by the end of 2018 and approximately 10,500 of these have been diagnosed. A total of 2,609 individuals were initiated onto hepatitis C treatment during financial year 2018/19.
    Scotland 23 Jul 2019 Reports & Research PDF
  • Drug-related infectious diseases in Europe
    This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.
    UK, Rest of World 16 Jul 2019 Reports & Research PDF
  • Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
    This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.
    Rest of World 09 Jul 2019 Reports & Research PDF
  • Information for GPs on the Infected Blood Inquiry
    This document from Public Health England provides information for GPs on the ongoing Infected Blood Inquiry, chaired by Sir Brian Langstaff. The document covers: why there is an Infected Blood Inquiry; what to advise if your patient thinks that they received blood in the 1970s/1980s; what to do if your patient is hepatitis C positive and is concerned a past transfusion
    UK 05 Jul 2019 Training, Reports & Research PDF
  • Hepatitis C: Progress towards achieving elimination in Wales
    Following an inquiry into hepatitis C, the Welsh Assembly Health, Social Care and Sport Committee published this report. The report makes four main recommendations to the Welsh Government: that the Welsh Government produces a comprehensive national elimination strategy for hepatitis C, with clear ambitious targets, and workforce planning built in, and provides sustainable funding until elimination is achieved; implementation of a targeted awareness raising campaign to reach out to at risk communities; to write to Local Health Board
    Wales 27 Jun 2019 Reports & Research, Strategy & Planning PDF
  • WHO progress report on HIV, viral hepatitis and STIs 2019
    The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.
    Rest of World 24 May 2019 Reports & Research, Strategy & Planning PDF
  • WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
    The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.
    UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF

Pages